Effectiveness of Bariatric Surgery for NAFLD/NASH

Recruiting Observational Study
Bariatric Surgery Candidate NAFLD NASH With Fibrosis
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
16 – 65
Sex
Any
Study type
Observational
Participants needed
320 (estimated)
Sponsor
Beijing Friendship Hospital · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
This is a prospective, multicenter cohort study, which subjects were obese patients requiring bariatric surgery. This study aims to explore the the effectiveness of bariatric surgery for NAFLD/NASH with fribrosis, to explore the differences in the effectiveness among sleeve gastrostomy \[SG\], Roux-en-Y gastric bypass \[RYGB\], or one anastomosis gastric bypass \[OAGB\], and to explore the indepe…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: \[For Base-NAFLD\] 1. Age between 16 and 65 years (all sexes). 2. Diagnosed with obesity according to the World Health Organization criteria for obesity in Asian populations and scheduled for a primary bariatric surgery at the participating centres. 3. Diagnosed with hepatic st…
Contacts

Zhongtao Zhang, M.D.;Ph.D.

+86-13801060364

zhangzht@ccmu.edu.cn

CONTACT

Mengyi Li, M.D.;Ph.D.

+86-15810993198

limengyi@ccmu.edu.cn

CONTACT